Inflammatory Bowel Disease and the Lungs

Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...

Michael Thase, MD, of the University of Pennsylvania explains the risks of using antipsychotics in the treatment of depression.

In this video, Pulmonology Consultant Advisory Board Member Michael Niederman, MD, from Weill Cornell Medical College, talks about the challenges that pulmonary and critical care physicians may...